VAP prevention: do we need more proof or more perspective? - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Assessing the Need for Enhanced Evidence or Broader Perspectives in VAP Prevention

  • By

  • Stijn Blot

  • Elena Conoscenti

  • Alexandre Boyer

  • August 11, 2026

Share

Objective:

To evaluate the impact of automated cuff pressure control and continuous subglottic secretion drainage on clinical outcomes in patients requiring mechanical ventilation.

Approach:
  • Study Design: A multicenter cluster-randomized trial comparing automated cuff pressure control with continuous subglottic secretion drainage to manual cuff control and intermittent drainage.
Key Findings:
  • Automated cuff control resulted in fewer measurements outside the target range and greater total volume of drained secretions.
  • The incidence of microbiologically documented VAP was lower in the automated group (10.2%) compared to the manual group (19.5%).
  • No significant difference in day-3 tracheobronchial colonization between groups.
  • The study raised questions about the reliability of colonization as an indicator of microaspiration.
Interpretation:

The findings indicate that automated systems may reduce VAP incidence, but the lack of difference in colonization raises questions.

Limitations:
  • The study's primary outcome, day-3 tracheobronchial colonization, may not accurately reflect microaspiration.
  • High antibiotic exposure among participants could bias colonization measurements.
  • The trial was underpowered to detect significant differences in tracheal mucosal damage.
Conclusion:

The evidence for the effectiveness of automated cuff pressure control and continuous SSD in preventing VAP remains insufficient.

Sources:

Original Source(s)

Related Content